Search results for "Fibrosis"

showing 10 items of 901 documents

Radiofrequency tissue volume reduction for treatment of auricle keloids

2010

Objectives/Hypothesis: Keloids are often refractive to treatment, and recurrences occur quite frequently. Radiofrequency tissue volume reduction (RFTVR) is a surgical technology that induces extensive fibrosis at the target tissues. Methods: We applied RFTVR in 14 patients (19 auricles, 5 patients treated bilaterally; 9 female, 5 male; range, 10–66 years) with keloids of the auricle. Keloids were located at the earlobe in 4 patients (5 auricles), helix in 9 patients (12 auricles), and at both earlobe and helix in 1 patient (2 auricles). In 6 patients (8 auricles) RFTVR was the sole treatment modality applied, and in 7 patients (10 auricles) intralesional steroid injection was also performed…

AdultMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentYoung AdultFibrosisSurgical technologymedicineHumansMinimally Invasive Surgical ProceduresChildEar DiseasesReduction (orthopedic surgery)EarlobeAgedAuriclebiologybusiness.industryPinnaMiddle Agedbiology.organism_classificationmedicine.diseaseSurgerymedicine.anatomical_structureOtorhinolaryngologyKeloidCatheter AblationFemalebusinessProgressive diseaseEar AuricleTissue volumeThe Laryngoscope
researchProduct

Suspicious liver nodule in chronic liver disease: Usefulness of a second biopsy

2018

International audience; Purpose: To assess the usefulness of a second biopsy when the first one was inconclusive in patients with a liver nodule found during the follow-up for chronic liver disease.Materials and methods: Among 381 patients (544 nodules) included in a prospective study designed to evaluate the accuracy of imaging for the diagnosis of small hepatocellular carcinoma (HCC) in chronic liver disease, 254 nodules were biopsied. The following histological results were considered as conclusive: HCC, dysplastic or regenerative nodule, and other identified tumors (benign or malignant). For nodules with inconclusive results (e.g. fibrosis or no definite focal lesion), a second biopsy w…

AdultMalemedicine.medical_specialtyCarcinoma Hepatocellular[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/ImagingBiopsyChronic liver disease030218 nuclear medicine & medical imagingLesion03 medical and health sciences0302 clinical medicineFibrosisBiopsyHumansMedicineRadiology Nuclear Medicine and imagingIn patientProspective StudiesProspective cohort studyAgedAged 80 and overRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryLiver DiseasesLiver NeoplasmsNodule (medicine)General MedicineMiddle Agedmedicine.disease3. Good healthHepatocellular carcinomaChronic DiseaseFemale030211 gastroenterology & hepatologyRadiologymedicine.symptombusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 I…

2013

Background & Aims: Few studies have evaluated the accuracy of ultrasonography in detecting steatosis in patients with chronic hepatitis C. We assessed its accuracy in detecting steatosis and factors that affect its diagnostic performance in consecutive patients with chronic hepatitis C virus genotype 1infection. Methods: We analyzed data from 515 patients with chronic hepatitis C, confirmed by liver biopsy, assessing anthropometric, biochemical, metabolic, virologic, and ultrasonography features. Transient elastography was performed to measure liver stiffness. Steatosis was identified with ultrasonography based on detection of a bright liver echo pattern. Results: Ultrasonography identified…

AdultMalemedicine.medical_specialtyCirrhosisGenotypeHepatitis C virusHepacivirusSettore MED/08 - Anatomia Patologicamedicine.disease_causeGastroenterologyBody Mass IndexPredictive Value of TestsInternal medicinemedicineHumansAgedSettore MED/12 - Gastroenterologiahcv fibrosis fibroscan steatosis histologyHepatologymedicine.diagnostic_testDiagnostic Tests Routinebusiness.industryGastroenterologyOdds ratioHepatitis C ChronicMiddle Agedmedicine.diseaseElasticityConfidence intervalFatty LiverLiverLiver biopsyElasticity Imaging TechniquesFemaleSteatosisbusinessTransient elastographyBody mass indexClinical Gastroenterology and Hepatology
researchProduct

The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods

2020

Background. Bariatric surgery patients have a higher prevalence of nonalcoholic fatty liver (NAFL) than the general population; however, its assessment and the accurate staging of fibrosis are often complicated because noninvasive tests are not very accurate in patients with morbid obesity, and liver biopsy cannot be performed as a routine exam. The aim of this study was to evaluate (A) the histological prevalence of NAFL, nonalcoholic steatohepatitis (NASH), and fibrosis in patients undergoing bariatric surgery; (B) the reliability of ultrasound (US) in diagnosing NAFL; and (C) the reliability of various fibrosis scoring systems for defining fibrosis. Methods. US and intraoperative liver b…

AdultMalemedicine.medical_specialtyCirrhosisSettore MED/09 - Medicina InternaArticle SubjectPopulationBariatric SurgeryPrevalence NAFLD Fibrosis Bariatric Surgery Non invasive diagnosis UltrasoundGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineFibrosisNon-alcoholic Fatty Liver DiseaseDiabetes mellitusNonalcoholic fatty liver diseasemedicinePrevalenceHumansObesityeducationNonalcoholic steatohepatitis (NASH)Retrospective StudiesUltrasonographyeducation.field_of_studyGeneral Immunology and Microbiologymedicine.diagnostic_testbusiness.industryFatty liverRRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseFibrosisSurgeryObesity Morbidultrasound (US)ROC Curve030220 oncology & carcinogenesisLiver biopsyMedicine030211 gastroenterology & hepatologyFemalebusinessResearch ArticleNonalcoholic fatty liver disease (NAFLD)BioMed Research International
researchProduct

Non-classic cystic fibrosis associated with D1152HCFTR mutation

2010

Burgel P-R, Fajac I, Hubert D, Grenet D, Stremler N, Roussey M, Siret D, Languepin J, Mely L, Fanton A, Labbe A, Domblides P, Vic P, Dagorne M, Reynaud-Gaubert M, Counil F, Varaigne F, Bienvenu T, Bellis G, Dusser D. Non-classic cystic fibrosis associated with D1152H CFTR mutation. Background: Limited knowledge exists on phenotypes associated with the D1152H cystic fibrosis transmembrane conductance regulator (CFTR) mutation. Methods: Subjects with a D1152H allele in trans with another CFTR mutation were identified using the French Cystic Fibrosis Registry. Phenotypic characteristics were compared with those of pancreatic insufficient (PI) and pancreatic sufficient (PS) cystic fibrosis (CF)…

AdultMalemedicine.medical_specialtyConsensusPancreatic diseaseAdolescentCystic FibrosisGENETICSmedicine.medical_treatmentCystic Fibrosis Transmembrane Conductance RegulatorCystic fibrosisGastroenterologyMembrane PotentialsCohort StudiesYoung AdultChloridesInterquartile rangeForced Expiratory VolumeInternal medicineCYSTIC_FIBROSISHumansMedicineLung transplantationGenetic Predisposition to DiseaseChildSweatExocrine pancreatic insufficiencyMUTATIONGenetics (clinical)AgedBronchiectasisbiologybusiness.industryHomozygoteMiddle Agedmedicine.diseaseCongenital absence of the vas deferensCystic fibrosis transmembrane conductance regulatorNasal MucosaEndocrinologyAmino Acid SubstitutionChild Preschoolbiology.proteinFemalebusiness
researchProduct

Differences of airway dimensions between patients with and without bronchiolitis obliterans syndrome after lung transplantation-Computer-assisted qua…

2016

Abstract Background The aim of our retrospective study was to determine whether a dedicated software for assessment of airway morphology can detect differences in airway dimensions between patients with and without bronchiolitis obliterans syndrome (BOS), regarded as the clinical correlate of chronic lung allograft rejection. Methods 12 patients with and 14 patients without diagnosis of BOS were enrolled in the study. Evaluation of bronchial wall area percentage (WA%) and bronchial wall thickness (WT) in all follow-up CT scans was performed using a semiautomatic airway assessment tool. We assessed temporal changes (ΔWA%, ΔWT) and compared these morphological parameters with forced expirator…

AdultMalemedicine.medical_specialtyCystic Fibrosismedicine.medical_treatmentHypertension PulmonaryPulmonary FibrosisBronchiolitis obliteransComputed tomographyBronchi030218 nuclear medicine & medical imagingPulmonary function testing03 medical and health sciences0302 clinical medicineForced Expiratory VolumeImage Processing Computer-AssistedMedicineLung transplantationHumansRadiology Nuclear Medicine and imagingBronchiolitis ObliteransLungRetrospective StudiesBronchial wallLungmedicine.diagnostic_testbusiness.industryRetrospective cohort studyGeneral MedicineSyndromerespiratory systemMiddle Agedmedicine.diseaseAllograftshumanitiesRespiratory Function Testsmedicine.anatomical_structure030228 respiratory systemPulmonary EmphysemaFemaleRadiologyAirwaybusinessTomography X-Ray ComputedFollow-Up StudiesLung TransplantationEuropean journal of radiology
researchProduct

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial

2004

We assessed the effectiveness and safety of an induction dose of peginterferon alfa-2b (PEG-IFN) plus ribavirin for initial treatment of patients with genotype 1 chronic HCV infection in a randomized, controlled, multicenter trial.Three hundred and eleven naïve patients infected with genotype 1 and chronic hepatitis were randomly assigned to 48-week treatment with PEG-IFN once weekly (80-100 micrograms depending on body weight for 8 weeks, followed by 50 micrograms for the next 40 weeks), or standard interferon alfa-2b (IFN) 6 million units on alternate days, both in combination with ribavirin (1000-1200 mg/day).PEG-IFN plus ribavirin significantly increased sustained virological response (…

AdultMalemedicine.medical_specialtyGenotypeCombination therapyFibrosiHepacivirusAlpha interferonHepacivirusInterferon alpha-2Antiviral AgentsGastroenterologyPolyethylene Glycolslaw.inventionchemistry.chemical_compoundRandomized controlled triallawMulticenter trialInternal medicineRibavirinmedicineHumansCombination therapyHepatologybiologybusiness.industryRibavirinfibrosisInterferon-alphavirus diseasesDrug ToleranceHepatitis CHepatitis C ChronicMiddle Agedbiology.organism_classificationmedicine.diseaseRecombinant Proteinsdigestive system diseasesMulticenter trial; Combination therapy; fibrosischemistryMulticenter trialImmunologyPeginterferon alfa-2bFemaleSafetybusinessmedicine.drugJournal of Hepatology
researchProduct

Genetic, andrological and clinical characteristics of patients with congenital bilateral absence of vas deferens

2001

Summary The possibility of retrieving spermatozoa from the epididymis allows patients with congenital bilateral absence of the vas deferens (CBAVD) to father a child by means of assisted reproduction techniques. This has, however, increased the chance of transmitting a mutated allele of the cystic fibrosis transmembrane conductance regulator (CFTR) gene which increases the risk of generating offspring with cystic fibrosis (CF). Because of the increased heterogeneity of the CFTR locus, the study of a discrete number of mutations, as usually carried out in a diagnostic work-up, is unable to ascertain the presence of a mutation in a relatively high proportion of the patients screened. In an at…

AdultMalemedicine.medical_specialtyGenotypeCystic Fibrosis Transmembrane Conductance Regulator/genetics; Vas Deferens/abnormalities; Urogenital Abnormalities/geneticsUrologyEndocrinology Diabetes and MetabolismPopulationCystic Fibrosis Transmembrane Conductance RegulatorGastroenterologyCystic fibrosisVas DeferensPregnancyInternal medicinemedicineHumansRespiratory functionSperm Injections IntracytoplasmicAlleleeducationSweat testeducation.field_of_studybiologymedicine.diagnostic_testbusiness.industryVas deferensPregnancy Outcomemedicine.diseaseEpididymisSpermatozoaCystic fibrosis transmembrane conductance regulatorVas Deferens/abnormalitiesEndocrinologymedicine.anatomical_structureReproductive MedicineUrogenital Abnormalities/geneticsUrogenital Abnormalitiesbiology.proteinCystic Fibrosis Transmembrane Conductance Regulator/geneticsFemalebusiness
researchProduct

Different patterns of myocardial iron distribution by whole-heart T2* magnetic resonance as risk markers for heart complications in thalassemia major.

2014

Background The multislice multiecho T2* cardiovascular magnetic resonance (CMR) technique allows to detect different patterns of myocardial iron overload (MIO). The aim of this cross-sectional study was to verify the association between cardiac complications (heart failure and arrhythmias), biventricular dysfunction and myocardial fibrosis with different patterns of MIO in thalassemia major (TM) patients. Methods We considered 812 TM patients enrolled in the Myocardial Iron Overload in Thalassemia (MIOT) Network. The T2* value in all the 16 cardiac segments was evaluated. Results We identified 4 groups of patients: 138 with homogeneous MIO (all segments with T2* < 20 ms), 97 with heterogene…

AdultMalemedicine.medical_specialtyHeart DiseasesThalassemiaIronMyocardial ironMagnetic Resonance Imaging CineMyocardial iron overloadYoung AdultRisk FactorsInternal medicineMedicineDistribution (pharmacology)HumansMultisliceChelation therapyCardiac complicationThalassemia majormedicine.diagnostic_testbusiness.industryMyocardiumbeta-ThalassemiaMagnetic resonance imagingmedicine.diseaseCross-Sectional StudiesHeart failureCardiologyMyocardial fibrosisCardiovascular magnetic resonanceFemaleCardiology and Cardiovascular MedicinebusinessInternational journal of cardiology
researchProduct

Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major

2009

Background: Cardiovascular magnetic resonance (CMR) by delayed enhancement (DE) enables visualisation of myocardial scarring, but no dedicated studies are available in thalassaemia major. Objective: To investigate the prevalence, extent, clinical and instrumental correlates of myocardial fibrosis or necrosis by DE CMR in patients with thalassaemia major. Patients: 115 Patients with thalassaemia major consecutively examined at an MRI laboratory. Methods: DE images were acquired to quantify myocardial scarring. Myocardial iron overload was determined by multislice multiecho T2*. Cine images were obtained to evaluate biventricular function. Results: DE areas were present in 28/115 patients (24…

AdultMalemedicine.medical_specialtyIron Overloadthalassaemia majorThalassemiaMagnetic Resonance Imaging CineCicatrixNecrosisFibrosisInternal medicineMyocardial scarringmedicineHumansMultisliceRetrospective Studiesmedicine.diagnostic_testbusiness.industryMyocardiumbeta-ThalassemiaMagnetic resonance imagingRetrospective cohort studymedicine.diseaseHemoglobinopathyCardiologyFemaleMyocardial fibrosismedicine.symptomCardiology and Cardiovascular MedicineNuclear medicinebusinessMagnetic Resonance AngiographyMyocardial scarring
researchProduct